169 related articles for article (PubMed ID: 34863906)
1. Integrating toxicokinetics into toxicology studies and the human health risk assessment process for chemicals: Reduced uncertainty, better health protection.
Claire T; Sean H
Regul Toxicol Pharmacol; 2022 Feb; 128():105092. PubMed ID: 34863906
[TBL] [Abstract][Full Text] [Related]
2. Streamlined chemical tests rebuffed.
Gilbert N
Nature; 2010 Jan; 463(7278):142-3. PubMed ID: 20075888
[No Abstract] [Full Text] [Related]
3. Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing--an integrated approach without additional animal use.
Saghir SA; Bartels MJ; Rick DL; McCoy AT; Rasoulpour RJ; Ellis-Hutchings RG; Sue Marty M; Terry C; Bailey JP; Billington R; Bus JS
Regul Toxicol Pharmacol; 2012 Jul; 63(2):321-32. PubMed ID: 22440553
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.
Tan YM; Barton HA; Boobis A; Brunner R; Clewell H; Cope R; Dawson J; Domoradzki J; Egeghy P; Gulati P; Ingle B; Kleinstreuer N; Lowe K; Lowit A; Mendez E; Miller D; Minucci J; Nguyen J; Paini A; Perron M; Phillips K; Qian H; Ramanarayanan T; Sewell F; Villanueva P; Wambaugh J; Embry M
Regul Toxicol Pharmacol; 2021 Dec; 127():105070. PubMed ID: 34718074
[TBL] [Abstract][Full Text] [Related]
5. Implementing a framework for integrating toxicokinetics into human health risk assessment for agrochemicals.
Terry C; Hays S; McCoy AT; McFadden LG; Aggarwal M; Rasoulpour RJ; Juberg DR
Regul Toxicol Pharmacol; 2016 Mar; 75():89-104. PubMed ID: 26472101
[TBL] [Abstract][Full Text] [Related]
6. Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: a cross-company review.
Sparrow SS; Robinson S; Bolam S; Bruce C; Danks A; Everett D; Fulcher S; Hill RE; Palmer H; Scott EW; Chapman KL
Regul Toxicol Pharmacol; 2011 Nov; 61(2):222-9. PubMed ID: 21855593
[TBL] [Abstract][Full Text] [Related]
7. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
Dixit R; Riviere J; Krishnan K; Andersen ME
J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
[TBL] [Abstract][Full Text] [Related]
8. From alternative methods to a new toxicology.
Hartung T
Eur J Pharm Biopharm; 2011 Apr; 77(3):338-49. PubMed ID: 21195172
[TBL] [Abstract][Full Text] [Related]
9. Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety.
Borgert CJ; Fuentes C; Burgoon LD
Arch Toxicol; 2021 Dec; 95(12):3651-3664. PubMed ID: 34623454
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on the use of alternative species in human health and ecological hazard assessments.
Perkins EJ; Ankley GT; Crofton KM; Garcia-Reyero N; LaLone CA; Johnson MS; Tietge JE; Villeneuve DL
Environ Health Perspect; 2013 Sep; 121(9):1002-10. PubMed ID: 23771518
[TBL] [Abstract][Full Text] [Related]
11. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
Tralau T; Oelgeschläger M; Gürtler R; Heinemeyer G; Herzler M; Höfer T; Itter H; Kuhl T; Lange N; Lorenz N; Müller-Graf C; Pabel U; Pirow R; Ritz V; Schafft H; Schneider H; Schulz T; Schumacher D; Zellmer S; Fleur-Böl G; Greiner M; Lahrssen-Wiederholt M; Lampen A; Luch A; Schönfelder G; Solecki R; Wittkowski R; Hensel A
Arch Toxicol; 2015 Jun; 89(6):823-50. PubMed ID: 25820917
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetics, dose-response, and risk assessment of nanomaterials: Methodology, challenges, and future perspectives.
Chen Q; Riviere JE; Lin Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1808. PubMed ID: 36416026
[TBL] [Abstract][Full Text] [Related]
13. Proper knowledge on toxicokinetics improves human hazard testing and subsequent health risk characterisation. A case study approach.
Bessems JG; Geraets L
Regul Toxicol Pharmacol; 2013 Dec; 67(3):325-34. PubMed ID: 24051162
[TBL] [Abstract][Full Text] [Related]
14. [Evidence-based toxicological evaluation of chemicals by group summaries].
Greim H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1417-25. PubMed ID: 19137217
[TBL] [Abstract][Full Text] [Related]
15. Regulatory toxicology: objectives and tasks defined by the working group of the German society of experimental and clinical pharmacology and toxicology.
Gelbke HP
Toxicol Lett; 2002 Feb; 126(3):159-60. PubMed ID: 11814701
[No Abstract] [Full Text] [Related]
16. The need for a formal invalidation process for animal and non-animal tests.
Balls M; Combes R
Altern Lab Anim; 2005 Jun; 33(3):299-308. PubMed ID: 16180982
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the proposed EU regulation concerning biocide products and its opportunities for alternative approaches and a toxicology for the 21st century.
Ferrario D; Rabbit RR
ALTEX; 2012; 29(2):157-72. PubMed ID: 22562488
[TBL] [Abstract][Full Text] [Related]
18. The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective.
Sewell F; Aggarwal M; Bachler G; Broadmeadow A; Gellatly N; Moore E; Robinson S; Rooseboom M; Stevens A; Terry C; Burden N
Toxicology; 2017 Aug; 389():109-117. PubMed ID: 28774667
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based toxicology: strait is the gate, but the road is worth taking.
Silbergeld E; Scherer RW
ALTEX; 2013; 30(1):67-73. PubMed ID: 23338807
[TBL] [Abstract][Full Text] [Related]
20. Non-animal approaches for toxicokinetics in risk evaluations of food chemicals.
Punt A; Peijnenburg AACM; Hoogenboom RLAP; Bouwmeester H
ALTEX; 2017; 34(4):501-514. PubMed ID: 28403478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
